Other

Interest receivable on interest rate and cross currency swaps

Moderna Interest receivable on interest rate and cross currency swaps decreased by 7.1% to $39.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 26.4%, from $53.00M to $39.00M. Over 5 years (FY 2020 to FY 2025), Interest receivable on interest rate and cross currency swaps shows an upward trend with a 36.1% CAGR.

Analysis

StatementBalance Sheet Statement
SectionOther
First reportedQ4 2018
Last reportedQ1 2026May 1, 2026
Metric ID: other_interest_receivable_current

Historical Data

18 periods
 Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$27.00M$36.00M$57.00M$54.00M$61.00M$69.00M$62.00M$52.00M$59.00M$62.00M$56.00M$50.00M$59.00M$53.00M$47.00M$40.00M$42.00M$39.00M
QoQ Change—+33.3%+58.3%-5.3%+13.0%+13.1%-10.1%-16.1%+13.5%+5.1%-9.7%-10.7%+18.0%-10.2%-11.3%-14.9%+5.0%-7.1%
YoY Change————+125.9%+91.7%+8.8%-3.7%-3.3%-10.1%-9.7%-3.8%+0.0%-14.5%-16.1%-20.0%-28.8%-26.4%
Range$27.00M – $69.00M
CAGR+9.0%
Avg YoY Growth+6.4%
Median YoY Growth-6.8%

Frequently Asked Questions

What is Moderna's interest receivable on interest rate and cross currency swaps?
Moderna (MRNA) reported interest receivable on interest rate and cross currency swaps of $39.00M in Q1 2026.
How has Moderna's interest receivable on interest rate and cross currency swaps changed year-over-year?
Moderna's interest receivable on interest rate and cross currency swaps decreased by 26.4% year-over-year, from $53.00M to $39.00M.
What is the long-term trend for Moderna's interest receivable on interest rate and cross currency swaps?
Over 5 years (2020 to 2025), Moderna's interest receivable on interest rate and cross currency swaps has grown at a 36.1% compound annual growth rate (CAGR), from $9.00M to $42.00M.